Warning: The NCBI web site requires JavaScript to function. more...
Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma.
Maximous DW, Abdel-Wanis ME, El-Sayed MI, Abd-Elsayed AA.
Int Arch Med. 2009 Mar 27;2(1):7.
Related citations
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL.
Int J Pancreatol. 2001;29(1):9-18.
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
Wilkowski R, Thoma M, Bruns C, Wagner A, Heinemann V.
JOP. 2006 Jul 10;7(4):349-60.
Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7.
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, Nishiyama K.
Ann Surg. 2009 Jul;250(1):88-95.
Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A.
Arch Surg. 2000 Jan;135(1):81-7; discussion 88.
Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.
Wilkowski R, Thoma M, Schauer R, Wagner A, Heinemann V.
World J Surg. 2004 Oct;28(10):1011-8. Epub 2004 Sep 29.
Primary advanced unresectable pancreatic cancer.
Wilkowski R, Wolf M, Heinemann V.
Recent Results Cancer Res. 2008;177:79-93. Review.
Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B, Hanlon AL, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Eisenberg BL, Cooper HS, Provins S, Coia LR.
Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):43-50.
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB.
J Clin Oncol. 2008 Jul 20;26(21):3487-95.
Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
Mehta VK, Fisher G, Ford JA, Poen JC, Vierra MA, Oberhelman H, Niederhuber J, Bastidas JA.
J Gastrointest Surg. 2001 Jan-Feb;5(1):27-35.
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM.
Ann Oncol. 2008 Jan;19(1):86-91. Epub 2007 Sep 17.
Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
Hidalgo M, Castellano D, Paz-Ares L, Gravalos C, Diaz-Puente M, Hitt R, Alonso S, Cortes-Funes H.
J Clin Oncol. 1999 Feb;17(2):585-92.
Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
Kornek GV, Pötter R, Selzer E, Schratter A, Ulrich-Pur H, Rogy M, Kraus G, Scheithauer W.
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):665-71.
Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
Mishra G, Butler J, Ho C, Melin S, Case LD, Ennever PR, Magrinat GC, Bearden JD, Minotto DC, Howerton R, Levine E, Blackstock AW.
Am J Clin Oncol. 2005 Aug;28(4):345-50.
Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D.
Ann Surg Oncol. 1999 Jan-Feb;6(1):38-45.
[Preoperative radiochemotherapy in pancreatic cancer: preliminary results].
Morganti AG, Trodella L, Valentini V, Doglietto GB, Ziccarelli P, Macchia G, Alfieri S, Smaniotto D, Luzi S, Brizi MG, Fadda G, Fiorino M, Di Gesú C, Cellini N.
Tumori. 1999 Jan-Feb;85(1 Suppl 1):S27-32. Italian.
[Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
Rau HG, Wichmann MW, Wilkowski R, Heinemann V, Sackmann M, Helmberger T, Dühmke E, Schildberg FW.
Chirurg. 2002 Feb;73(2):132-7. German.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on